glp-1 drugs alzheimer's Role of glucagon-like peptide-1 receptor agonists in disease and Parkinson's disease | Journal of Biomedical Science Truth or Myth: GLP-1 medications

A candidate NAD+ transporter in an intracellular bacterial symbiont related to Chlamydiae

People with gut issues often see dramatic improvements with IV vitamin drip infusions

In its CRL announcement, ARS said it had aligned with the FDA on physician labeling and post-market requirements, which included a repeat-dose study of neffy under allergen-induced allergic rhinitis conditions

Chaperone-mediated autophagy: roles in disease and aging

The unbalanced regulation of the glutathione synthesis coupled with the rapid and steady increase of glutathione abundance in the wheat tissue of the infested resistant plants suggested that the -glutamylcysteine synthetase might be either inhibited by a negative feedback from GSH, or it is not the rate-limiting enzyme in the glutathione synthetic pathway in wheat plants under our experimental conditions

While your body produces it on its own, levels can decline with age